Evaluation of Technological Innovation in Radiotherapy
Cancer | Radiotherapy Side EffectProspective cohort study of patients receiving standard-care radiotherapy is paramount to a better understanding of radiation effects and longterm outcomes.
The primary objective is to determine the feasibility of establishing infrastructure to systematically collect clinical data, patient-reported outcomes, and imaging data from daily radiotherapy practice.
Secondary objectives are to provide a control cohort for comparative effectiveness research of investigational interventions through a cmRCT design; compare imaging features with clinical outcomes; understand dose-effect relationships; quantify imaging quality metrics.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
18 and up
Participation Criteria
Inclusion Criteria:
* Ability to provide informed consent
* Receiving radiotherapy or brachytherapy
Exclusion Criteria:
-
Study Location
London Health Regional Cancer Centre
London Health Regional Cancer CentreLondon, Ontario
Canada
Contact Study Team
CHUQ
CHUQQuébec, Quebec
Canada
Contact Study Team
Centre Hospitalier de l'Université de Montréal
Centre Hospitalier de l'Université de MontréalMontréal, Quebec
Canada
Contact Study Team
Princess Margaret Cancer Centre
Princess Margaret Cancer CentreToronto, Ontario
Canada
Contact Study Team
Centre de santé et de services sociaux de Laval
Centre de santé et de services sociaux de LavalLaval, Quebec
Canada
Contact Study Team
Marie-Andrée Fortin, MD
- Study Sponsored By
- Centre hospitalier de l'Université de Montréal (CHUM)
- Participants Required
- More Information
- Study ID:
NCT03378856